Reuters was first to report Temasek Holdings is exploring selling Advanced MedTech, after the medical devices firm, fully owned by the Singaporean state investor, received interest from suitors, including buyout funds. Two investment banks have been tapped to launch a sale process for Singapore-headquartered MedTech, which could be valued at roughly $1 billion.
The post Reuters reveals Singapore’s Temasek considers sale of Advanced MedTech, likely valued at about $1 bln appeared first on Reuters News Agency.
Some of the links in this article are "affiliate links", a link with a special tracking code. This means if you click on an affiliate link and purchase the item, we will receive an affiliate commission. The price of the item is the same whether it is an affiliate link or not. Regardless, we only recommend products or services we believe will add value to our readers. By using the affiliate links, you are helping support our Website, and we genuinely appreciate your support.